Clinical trials and fibromyalgia Archives

Abstract Number: 46 • ACR/ARHP Annual Meeting 2016
Novel Composite Responder Endpoints for Fibromyalgia Therapy Assessment
R Michael Gendreau¹, Lesley Arnold², Daniel J. Clauw³, Judith Gendreau⁴, Bruce Daugherty⁴ and Seth Lederman⁴, ¹Gendreau Consulting LLC, Poway, CA, ²University of Cincinnati, Cincinnati, OH, ³Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI, ⁴Tonix Pharmaceuticals, New York, NY
Background/Purpose: Novel composite responder definitions for fibromyalgia (FM) clinical trials have been proposed by the Outcome Measures in Rheumatology (OMERACT) FM subcommittee. These definitions which…
Abstract Number: 1861 • ACR/ARHP Annual Meeting 2012
Efficacy and Safety of Pregabalin in Japanese Patients with Fibromyalgia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase III Trial and Open-Label Extension Study
Hiroyoshi Ohta¹, Masayuki Ohkura¹, Makoto Suzuki¹, Hiroshi Oka², Chie Usui³ and Kusuki Nishioka⁴, ¹Pfizer Japan Inc, Tokyo, Japan, ²Rheumatic Disease Center, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan, ³Department of Psychiatry, Juntendo University School of Medicine, Juntendo University Nerima Hospital, Tokyo, Japan, ⁴Institute of Innovative Medical Science and Education, Tokyo Medical University, Tokyo, Japan
Background/Purpose: Fibromyalgia (FM) is a common, chronic pain disorder, however, at the time of this study there was no approved medicine for FM patients in…
Abstract Number: 1872 • ACR/ARHP Annual Meeting 2012
Quality of Reporting in Pharmacological Randomized Controlled Trials for Fibromyalgia
Karen Yeter¹, Winnie Pang², Nasim A. Khan³ and Karina D. Torralba², ¹Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA, ²Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA, ³Rheumatology, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR
Background/Purpose: Randomized controlled trials (RCTs) are considered the gold standard for assessment of healthcare interventions. Recently, there have been growing concerns about the quality of…

Abstracts tagged "Clinical trials and fibromyalgia"

Novel Composite Responder Endpoints for Fibromyalgia Therapy Assessment

Efficacy and Safety of Pregabalin in Japanese Patients with Fibromyalgia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase III Trial and Open-Label Extension Study

Quality of Reporting in Pharmacological Randomized Controlled Trials for Fibromyalgia